Enrolling By Invitation NA INTERVENTIONAL 2-arm NCT06971445

Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy (OM3HIVPROUTINF)

Effect of Polyunsaturated Fatty Acids Omega-3 Supplementation on Pregnancy Outcomes and Inflammation Markers in Pregnant Women HIV+, With Antiretroviral Therapy, Randomized Clinical Trial.

Sponsor: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

Conditions Pregnant HIV Positive Women

Interventions Olive oil (placebo) omega-3 polyunsaturated fatty acids (PUFA n-3)

Updated 4 times since 2025 Last updated: Sep 4, 2025 Started: May 14, 2025 Primary completion: Jul 31, 2028 Completion: Dec 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pregnant HIV Positive Women and is currently ongoing. Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Enrolling By Invitation NA
Sep 2025 — Oct 2025 [monthly]

Enrolling By Invitation NA
Jul 2025 — Sep 2025 [monthly]

Enrolling By Invitation NA

Status: Not Yet Recruiting → Enrolling By Invitation
Jun 2025 — Jul 2025 [monthly]

Not Yet Recruiting NA

First recorded

May 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

Data source: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico